Factor IX Complex (Human)
- Generic Name
- Factor IX Complex (Human)
- Brand Names
- Profilnine
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 37224-63-8
- Unique Ingredient Identifier
- FW411QXD5M
- Background
Factor IX Complex is a sterile, lyophilized concentrate composed of a number of Vitamin K-dependent clotting factors found in functioning human plasma. Also known as prothrombin complex concentrate, products containing this complex often include Factor IX (antihemophilic factor B), Factor II (prothrombin), Factor X (Stuart-Prower Factor), and low levels of F...
- Indication
Factor IX Complex is indicated for the prevention and control of hemorrhagic episodes in hemophilia B patients. It is also indicated for the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with acute major bleeding or who require rapid reversal of therapy.
- Associated Conditions
- Bleeding, Hemorrhage, Intracranial Hemorrhages
- Associated Therapies
- Perioperative bleeding management therapy
Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial Hemorrhage
- Conditions
- Interventions
- First Posted Date
- 2008-10-10
- Last Posted Date
- 2011-11-24
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 2
- Registration Number
- NCT00770718
Prothrombin Complex Concentrate for Anticoagulant Reversal
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2011-02-11
- Lead Sponsor
- CSL Behring
- Target Recruit Count
- 40
- Registration Number
- NCT00168077
- Locations
- 🇨ðŸ‡
Clinical Trials Registration Coordinator, Zuerich, Switzerland
🇩🇪For information on sites in Europe, please contact our clinical research team in, Marburg, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.